All Stories

  1. Discovery of Polyphenolic Compounds from Mangifera indica as Potent Therapeutics for Strongyloides stercoralis Infection via Computer-aided Drug Design
  2. Targeted Anti-Inflammatory Effects of Chloramphenicol via TLR4 Inhibition in Postoperative Hemorrhoid Treatment: A Clinico- Computational Cohort Study
  3. Breaking Boundaries in Cancer Therapy: Harnessing Chromothripsisinduced Mutations for Targeted Bcl-2 Protein Destabilization
  4. Unlocking Platelet Mechanisms through Multi-omics Integration: A Brief Review
  5. Deciphering Molecular Mechanisms of Carbon Tetrachloride- Induced Hepatotoxicity: A Brief Systematic Review
  6. Chemical Analysis and Molecular Modelling of Cyclodextrin-Formulated Propofol and Its Sodium Salt to Improve Drug Solubility, Stability and Pharmacokinetics (Cytogenotoxicity)
  7. Linking Cerebrovascular Dysfunction to Age-Related Hearing Loss and Alzheimer’s Disease—Are Systemic Approaches for Diagnosis and Therapy Required?
  8. In silico High-Throughput Screening of ZINC Database of Natural Compounds to Identify Novel Histone Deacetylase Inhibitors
  9. Cyclodextrin-Based Polymeric Materials Bound to Corona Protein for Theranostic Applications
  10. The Role of Clusterin Transporter in the Pathogenesis of Alzheimer’s Disease at the Blood–Brain Barrier Interface: A Systematic Review
  11. In silico investigation of nonsynonymous single nucleotide polymorphisms in BCL2 apoptosis regulator gene to design novel protein‐based drugs against cancer
  12. The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function
  13. Supervised Machine Learning Models and Protein-Protein Interaction Network Analysis of Gene Expression Profiles Induced by Omega-3 Polyunsaturated Fatty Acids
  14. The Conspicuous Link between Ear, Brain and Heart–Could Neurotrophin-Treatment of Age-Related Hearing Loss Help Prevent Alzheimer’s Disease and Associated Amyloid Cardiomyopathy?
  15. Comparative chemical examination of inclusion complexes formed with β-cyclodextrin derivatives and basic amino acids
  16. Novel Approach for Characterizing Propofol Binding Affinities to Serum Albumins from Different Species
  17. Structural Comparison of Diverse HIV-1 Subtypes using Molecular Modelling and Docking Analyses of Integrase Inhibitors
  18. Supervised machine learning models and protein-protein interaction network analysis of gene expression profiles induced by omega-3 polyunsaturated fatty acids
  19. Supervised Machine Learning Models and Protein-protein Interaction Network Analysis of Gene Expression Profiles Induced by Omega-3 Polyunsaturated Fatty Acids
  20. Synthesis, Biochemical Characterization, and Theoretical Studies of Novel β-Keto-enol Pyridine and Furan Derivatives as Potent Antifungal Agents
  21. Modeling of shotgun sequencing of DNA plasmids using experimental and theoretical approaches
  22. Phytochemical and pharmacological attributes of piperine: A bioactive ingredient of black pepper
  23. Degradation of pristine and oxidized single wall carbon nanotubes by CYP3A4
  24. Biodegradation of naphthalene by immobilized Pseudomonas sp. consortium
  25. Detailed chemical characterization and molecular modeling of serotonin inclusion complex with unmodified β-cyclodextrin
  26. Computational assessments of diastereoselective [4+2] cycloaddition and 1,3-borotopic shift of a dearomatized tertiary boronic ester intermediate: reactivities explained through transition-state distortion energies
  27. Diadzein complexation with unmodified cyclodextrins: A detailed experimental and theoretical study
  28. Diadenosine-Polyphosphate Analogue AppCH2ppA Suppresses Seizures by Enhancing Adenosine Signaling in the Cortex
  29. Role of Milk-Derived Antibacterial Peptides in Modern Food Biotechnology: Their Synthesis, Applications and Future Perspectives
  30. Effects of secondary carbon supplement on biofilm-mediated biodegradation
  31. In Silico Designed Axl Receptor Blocking Drug Candidates Against Zika Virus Infection
  32. Computational simulation and modeling of the blood–brain barrier pathology
  33. Investigation of Crystalline and Amorphous Forms of Aluminum and Its Alloys: Computational Modeling and Experiment
  34. Enhanced biodegradation of mixed PAHs by mutated naphthalene 1,2-dioxygenase
  35. In silico investigation of propofol binding sites in human serum albumin using explicit and implicit solvation models
  36. In Silico Modeling of Indigo and Tyrian Purple Single-Electron Nano-Transistors Using Density Functional Theory Approach
  37. In silico models for nanotoxicity evaluation and prediction at the blood-brain barrier level: A mini-review
  38. Solubility profiles, hydration and desolvation of curcumin complexed with γ-cyclodextrin and hydroxypropyl-γ-cyclodextrin
  39. A Novel Approach for the Control of Inflammatory Pain: Prostaglandin E2 Complexation by Randomly Methylated β-Cyclodextrins
  40. Characterization, in Vivo Evaluation, and Molecular Modeling of Different Propofol–Cyclodextrin Complexes To Assess Their Drug Delivery Potential at the Blood–Brain Barrier Level
  41. Evaluation of the potential toxicity of unmodified and modified cyclodextrins on murine blood-brain barrier endothelial cells
  42. Gene expression profiles and protein–protein interaction network analysis in AIDS patients with HIV-associated encephalitis and dementia
  43. Sevoflurane-Sulfobutylether-β-Cyclodextrin Complex: Preparation, Characterization, Cellular Toxicity, Molecular Modeling and Blood-Brain Barrier Transport Studies
  44. Blood–brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate
  45. Ionization States, Cellular Toxicity and Molecular Modeling Studies of Midazolam Complexed with Trimethyl-β-Cyclodextrin
  46. In silico predictive model to determine vector-mediated transport properties for the blood–brain barrier choline transporter
  47. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model
  48. In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions
  49. Three-dimensional quantitative structure–activity relationship and docking studies in a series of anthocyanin derivatives as cytochrome P450 3A4 inhibitors
  50. Evaluation and Prediction of the HIV-1 Central Polypurine Tract Influence on Foamy Viral Vectors to Transduce Dividing and Growth-Arrested Cells
  51. Glucocorticoids and endothelial cell barrier function
  52. Analysing molecular polar surface descriptors to predict blood-brain barrier permeation
  53. Pharmacokinetic Delivery and Metabolizing Rate of Nicardipine Incorporated in Hydrophilic and Hydrophobic Cyclodextrins Using Two‐Compartment Mathematical Model
  54. Multidrug resistance protein P-gp interaction with nanoparticles (fullerenes and carbon nanotube) to assess their drug delivery potential: a theoretical molecular docking study
  55.  α-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies
  56. MOLECULAR DYNAMICS SIMULATION OF POPC AND POPE LIPID MEMBRANE BILAYERS ENFORCED BY AN INTERCALATED SINGLE-WALL CARBON NANOTUBE